We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Neurostimulation System Highly Effective in Cluster Headache

By HospiMedica International staff writers
Posted on 20 Feb 2013
A new device that is based on stimulation of the sphenopalatine ganglion (SPG) helps reduce the frequency of cluster headache attacks.

The ATI Neurostimulation System is a novel, rechargeable system, with an implantable miniaturized neurostimulator (smaller than an almond) that is placed via the mouth, leaving no externally visible scars. More...
Designed for the treatment of severe headache, the neurostimulator is activated using an external remote controller that is held up to the cheek, allowing the patient to deliver as-needed stimulation to relieve the attack. After a headache is treated, the remote controller is simply moved away, turning off the stimulation therapy. The ATI Neurostimulation System is a product of Autonomic Technologies (ATI; Redwood City, CA, USA), and has received the European Community (CE) marking of approval.

In a placebo-controlled clinical study, the ATI Neurostimulation System demonstrated effectiveness in treating cluster headache, and provided significant improvement in patient quality of life and headache disability. Pain relief at 15 minutes was achieved in 67.1% of treated attacks, compared to 7.4% of sham treated attacks. Pain freedom at 15 minutes was achieved in 34.1% of treated attacks, compared to 1.5% of sham treated attacks. The average number of cluster attacks per week was reduced by 31%, and 43% of patients experienced an average reduction of 88% in the number of attacks suffered. The study results were published early online on February 6, 2013, in Cephalalgia.

“Cluster headaches cause so much disability that patients are often unable to function normally,” said lead author Prof. Jean Schoenen, MD, PhD, coordinator of the headache research unit at the University of Liege (Belgium). “Current preventive treatments are often ineffective, and in many patients acute and preventive treatments may not be tolerated or are contraindicated. This new and innovative therapy offers a way for a significant number of patients to control the debilitating pain of cluster headache.”

Cluster headache is a highly disabling chronic neurological condition characterized by intense stabbing pain in the area of one eye, often accompanied by swelling, tears, and nasal congestion. Patients suffering from cluster headache may experience multiple attacks daily or almost daily, with each attack lasting between 15 minutes and three hours. Often called “suicide headaches” because of their severity, it is estimated that over 600,000 people across Europe alone suffer from cluster headaches.

Related Links:

Autonomic Technologies
University of Liege



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Hybrid Arch Device
Neo EDE
New
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The new Cora Torqueable Microcatheters expand our coronary portfolio supporting patients with coronary artery disease (photo courtesy of Reflow Medical)

Torqueable Microcatheters Enhance Navigation in Complex Coronary Lesions

Interventional cardiologists frequently encounter tortuous vessels and heavily calcified or fibrotic coronary lesions that complicate guidewire control and device delivery. Stable, predictable torque and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.